458
Views
5
CrossRef citations to date
0
Altmetric
Original Research Articles

Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study

, , &
Article: 20282 | Received 15 Dec 2012, Accepted 02 Apr 2013, Published online: 13 May 2013

References

  • Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, etal. Hepatocellular carcinoma: epidemiology, diagnosis and treatment. Gut. 2009; 53: 1356–62.
  • McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2008; 19: 3–23.
  • El-Sera HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2009; 35: 72–8.
  • Beasley RP, Hwang LY. Overview on the epidemiology of hepatocellular carcinoma. Viral Hepand Liver Dis. 2001; 5: 532–5.
  • Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma in European countries. Can J Gastroenterol. 2010; 14: 703–9.
  • Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the world from 1975 to 2010. J Clin Oncol. 2009; 27: 1485–91.
  • International Agency for Research on Cancer. Cancer research for cancer prevention. France: Lyon. [cited 2012 Mar 30]. Available from: http://www.iarc.fr/.
  • Benvegnu L, Alberti A. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Res. 2001; 52: 199–207.
  • Chen CJ. Hepatitis B and C risk factors for liver cancer. Lancet Infect Dis. 2002; 2: 879.
  • . 2011; Feb. 1 Russia: Moscow. (in Russian). [The annual report of the main indicators in public health in Russia].
  • . 2011; Mar. 1 Russia: Arkhangelsk. (in Russian). [The main indicators of the Arkhangelsk region 2002–2010].
  • Vaktskjold A, Lebedintseva JA, Korotov DS, Tkatsjov AV, Podjakova TS, Lund E. Cancer incidence in Arkhangelskaja Oblast in Northwestern Russia. The Arkhangelsk Cancer Registry. BMC Cancer. 2005; 5: 82.
  • IDC-10: the international classification of diseases 10. 1995; Geneva, Switzerland: WHO. [cited 2010 Feb 27]. Available from: http://www.who.int/classifications/icd/en/.
  • Sherlock S, Pooley Y. Diseases of the liver and billary system. 714. 714. 10th ed. London: Blackwell Science; 2008.
  • Schoniger-Hekele M, Muller C, Kutilek M, Oesterrreicher C, Ferenci P, Gamgl A, etal. Viral hepatitis in Central Europe: prognostic features and survival. Gut. 2007; 48: 103–9.
  • Beasley RP. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. J Clin Epidemiol. 2010; 6: 118–26.
  • Yao FY. Should surveillance for hepatocellular carcinoma be increased in patients with cirrhosis and small liver nodules infected hepatitis C virus?. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 544–5.
  • Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology. 2004; 106: 1676–97.
  • Wörns MA, Bosslet T, Victor A, Koch S, Hoppe-Lotichius M, Heise M, etal. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver. Scand J Gastroenterol. 2012; 4: 718–28.
  • Sylla A, Diallo MS, Castegnaro J, Wild CP. Interactions between hepatitis B and C virus infection and the development of hepatocellular carcinoma: a molecular epidemiological approach. Mutat Res. 2009; 428: 187.
  • Santantonio T, Sinisi E, Guastadisegni A, Casalino M, Mazzola M, Gentile A, etal. Natural course of liver cancer. Dig Liver Dis. 2008; 35: 104–13.